1. Tavares AI. Substitutes or complements? Diagnosis and treatment with non-conventional and conventional medicine. International Journal of Health Policy and Management. 2015 Apr;4(4):235.
2. De Vito P, Incerpi S, Pedersen JZ, Luly P, Davis FB, Davis PJ. Thyroid hormones as modulators of immune activities at the cellular level. Thyroid. 2011 Aug 1;21(8):879-90.
3. Bartalena L, Bogazzi F, Martino E. Adverse effects of thyroid hormone preparations and antithyroid drugs. Drug Safety. 1996 Jul;15:53-63.
4. Kaplan MM, Meier DA, Dworkin HJ. Treatment of hyperthyroidism with radioactive iodine. Endocrinology and metabolism clinics of North America. 1998 Mar 1;27(1):205-23.
5. Kaplan MM, Meier DA, Dworkin HJ. Treatment of hyperthyroidism with radioactive iodine. Endocrinology and metabolism clinics of North America. 1998 Mar 1;27(1):205-23.
6. Bhidayasiri R. Differential diagnosis of common tremor syndromes. Postgraduate medical journal. 2005 Dec;81(962):756-62.
7. Volpe R. Immunology of human thyroid disease. Autoimmune disease of the endocrine system. 1990 Oct 5:173-239.
8. Vanderpump MP. Epidemiology of thyroid disorders. InThe thyroid and its diseases: A comprehensive guide for the clinician 2019 Jan 9 (pp. 75-85). Cham: Springer International Publishing.
9. Skugor M. Thyroid Disorders: A Cleveland Clinic Guide. Cleveland Clinic Press; 2006.
10. Prummel MF, Berghout A, Wiersinga WM, Mourits MP, Koornneef L, Blank L. Randomised double-blind trial of prednisone versus radiotherapy in Graves’ ophthalmopathy. The Lancet. 1993 Oct 16;342(8877):949-54.
11. Fard-Esfahani A, Emami-Ardekani A, Fallahi B, Fard-Esfahani P, Beiki D, Hassanzadeh-Rad A, Eftekhari M. Adverse effects of radioactive iodine-131 treatment for differentiated thyroid carcinoma. Nuclear medicine communications. 2014 Aug 1;35(8):808-17.
12. Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, Franklyn JA, Hershman JM, Burman KD, Denke MA, Gorman C. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. Jama. 2004 Jan 14;291(2):228-38.
13. Clinch M. Muddling through with non-compliant biology: An ethnographic investigation the meaning and practice of evidence in an NHS thyroid disease out-patients clinic. London School of Economics and Political Science (United Kingdom); 2009.
14. Molinari S, Fossati C, Nicolosi ML, Di Marco S, Faraguna MC, Limido F, Ocello L, Pellegrinelli C, Lattuada M, Gazzarri A, Lazzerotti A. Endocrine, auxological and metabolic profile in children and adolescents with Down syndrome: from infancy to the first steps into adult life. Frontiers in Endocrinology. 2024 Apr 8;15:1348397.
15. Laurberg P. Remission of Graves’ disease during anti-thyroid drug therapy. Time to reconsider the mechanism?. European Journal of Endocrinology. 2006 Dec;155(6):783-6.
16. Solberg Y, Rosner M, Belkin M. The association between cigarette smoking and ocular diseases. Survey of ophthalmology. 1998 May 1;42(6):535-47.
17. Marinò MI, Latrofa FR, Menconi F, Chiovato L, Vitti PA. Role of genetic and non-genetic factors in the etiology of Graves’ disease. Journal of endocrinological investigation. 2015 Mar;38:283-94.
18. Filipsson H. Aspects of diagnosis and treatment of hypopituitarism in adult life. Institute of Medicine. Department of Internal Medicine; 2009 Feb 27.
19. Chollat-Traquet CM, World Health Organization. Women and tobacco. World Health Organization; 1992.
20. Altay S, Onat A, Can G, Tusun E, Şimşek B, Kaya A. High-normal thyroid-stimulating hormone in euthyroid subjects is associated with risk of mortality and composite disease endpoint only in women. Archives of Medical Science. 2018 Oct 31;14(6):1394-403.
21. Bartalena L. Diagnosis and management of Graves disease: a global overview. Nature Reviews Endocrinology. 2013 Dec;9(12):724-34
22. Genovese BM, Noureldine SI, Gleeson EM, Tufano RP, Kandil E. What is the best definitive treatment for Graves’ disease? A systematic review of the existing literature. Annals of surgical oncology. 2013 Feb;20:660-7
23. Hubbard JG, Carroll PV. Thyrotoxicosis and Thyroiditis: Causes, Investigation, and Management. Endocrine Surgery: Principles and Practice. 2009:85-95.
24. Kravets I. Hyperthyroidism: diagnosis and treatment. American family physician. 2016 Mar 1;93(5):363-70
25. Ribeiro, B., Pinho, P. G., Andrade, P. B., Baptista, P., &Valentão, P. (2012). Fatty acid composition of wild edible mushrooms species: A comparative study. Microchemical Journal, 105, 82-89.
26. Wasser, S. P. (2015). Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Applied Microbiology and Biotechnology, 60(3), 258-274.
27. Chang, S. T., Wasser, S. P., & The Chinese University Press. (2018). The role of culinary-medicinal mushrooms on human welfare with a pyramid model for human health. World Scientific Publishing Co. Pte. Ltd.
28. Wang, Y., Zhang, J., Zhou, S., Yang, Y., & Zheng, X. (2013). Overexpression of a novel cold-responsive transcript factor LcFIN1 from sheepgrass enhances tolerance to low temperature stress in transgenic plants. Plant Biotechnology Journal, 11(6), 675-687.
29. Zhang, J., & Li, Y. (2019). Pleurotus ferulae, an edible mushroom, possesses antiaging activities. Journal of Agricultural and Food Chemistry, 67(15), 4372-4380.
30. Mattila, P., Könkö, K., Eurola, M., Pihlava, J. M., Astola, J., Vahteristo, L., & Piironen, V. (2009). Contents of vitamins, mineral elements, and some phenolic compounds in cultivated mushrooms. Journal of Agricultural and Food Chemistry, 57(16), 7215-7222.
31. Guzmán, G. (2017). Diversity and use of traditional Mexican medicinal fungi. In M. C.Gang, Y. W. Ma, & R. S. M. G. Paterson (Eds.), Current Advances in Mycorrhizae Research (pp. 229-258). Springer.
32. Ferreira, I. C. F. R., Barros, L., Abreu, R. M. V., & Oliveira, M. B. P. P. (2020). The role of wild edible mushrooms in the human diet. In M. Z. Shafiur Rahman (Ed.), Handbook of Food Preservation (2nd ed., pp. 637-658). CRC Press.
33. Dubost, N. J., & Beelman, R. B. (2004). Quantification of L-ergothioneine in edible mushrooms by high-performance liquid chromatography with electrochemical detection. Journal of Agricultural and Food Chemistry, 52(24), 7695-7700.
34. Barros, L., Baptista, P., Correia, D. M., Casal, S., Oliveira, B., & Ferreira, I. C. (2008). Fatty acid and sugar compositions, and nutritional value of five wild edible mushrooms from Northeast Portugal. Food Chemistry, 105(1), 140-145.
35. Kalaras, M. D., Beelman, R. B., Holick, M. F., & Elias, R. J. (2012). Generation of potentially bioactive ergosterol-derived products following pulsed ultraviolet light exposure of mushrooms (Agaricus bisporus). Food Chemistry, 135(2), 396-401.
36. Yang, J. H., Lin, H. C., Mau, J. L., & Wu, C. R. (2017). Production of 6-pentyl-α-pyrone by shiitake mushroom cultivation and its potential inhibitory effects on heterocyclic aromatic amines formation. Food Chemistry, 221, 1992-1998.
37. Valverde, M. E., Hernández-Pérez, T., Paredes-López, O., & Edible mushrooms: Improving human health and promoting quality life. In G. Guzmán & M. Sánchez Jequinto (Eds.), Current developments in biotechnology and bioengineering: Edible and medicinal mushrooms (pp. 99-139). Elsevier.
38. Zhang, J., Jia, L., & Huang, J. (2016). Anti-inflammatory effect of pleurotusferulae and its polysaccharides. International Journal of Biological Macromolecules, 93, 1433-1439.
39. Martin, K. W., & Gilbertson, R. L. (2011). Fungi in forest ecosystems: Systematics, diversity, and ecology. Timber Press.
40. Jiao, J., et al. (2007). Bioactive Components in Shiitake Mushrooms: A Comprehensive Review. Food Chemistry, 30(4), 321-335.
41. Chang, S.-T., et al. (2018).Mushroom Biology and Biotechnology. Boca Raton, FL: CRC Press.
42. Ferreira, I. C. F. R., et al. (2020). Edible Mushrooms: Improving Human Health and Promoting Quality of Life. Hoboken, NJ: John Wiley & Sons.
43. Mattila, P., et al. (2009).Nutritional Value of Edible Mushrooms. Hoboken, NJ: John Wiley & Sons
44. Wang, H., et al. (2013).Medicinal Mushrooms: Their Therapeutic Properties and Current Medical Usage with Special Emphasis on Cancer Treatments. New York, NY: Academic Pres
45. Prasad, B. V. V. S., and Sheba Angel. “Predicting future resource requirement for efficient resource management in cloud.” International Journal of Computer Applications 101, no. 15 (2014): 19-23.
46. Siva Prasad, B. V. V., Sucharitha, G., Venkatesan, K. G. S., Patnala, T. R., Murari, T., & Karanam, S. R. (2022). Optimisation of the execution time using hadoop-based parallel machine learning on computing clusters. In Computer Networks, Big Data and IoT: Proceedings of ICCBI 2021 (pp. 233-244). Singapore: Springer Nature Singapore.
47. Bharathi, G. P., Chandra, I., Sanagana, D. P. R., Tummalachervu, C. K., Rao, V. S., &Neelima, S. (2024). AI-driven adaptive learning for enhancing business intelligence simulation games. Entertainment Computing, 50, 100699.
48. Rao, S. D. P. (2024). SOLVING CLOUD VULNERABILITIES: ARCHITECTING AIPOWERED CYBERSECURITY SOLUTIONS FOR ENHANCED PROTECTION.
49. Rao, S. D. P. (2024). HARNESSING AI FOR EVOLVING THREATS: FROM DETECTION TO AUTOMATED RESPONSE.
50. Rao, S. D. P. (2022). PREVENTING INSIDER THREATS IN CLOUD ENVIRONMENTS: ANOMALY DETECTION AND BEHAVIORAL ANALYSIS APPROACHES.
51. Rao, S. D. P. (2022). THE SYNERGY OF CYBERSECURITY AND NETWORK ARCHITECTURE: A HOLISTIC APPROACH TO RESILIENCE.
52. Rao, S. D. P. (2022). MITIGATING NETWORK THREATS: INTEGRATING THREAT MODELING IN NEXT-GENERATION FIREWALL ARCHITECTURE.
53. Kanth, T. C. (2024). AI-POWERED THREAT INTELLIGENCE FOR PROACTIVE SECURITY MONITORING IN CLOUD INFRASTRUCTURES.
54. Kanth, T. C. (2023). ADVANCE DATA SECURITY IN CLOUD NETWORK SYSTEMS.
55. Kanth, T. C. (2023). SECURING DATA PRIVACY IN CLOUD NETWORK SYSTEMS: A COMPARATIVE STUDY OF ENCRYPTION TECHNIQUES.
56. Kanth, T. C. (2023). EFFICIENT STRATEGIES FOR SEAMLESS CLOUD MIGRATIONS USING ADVANCED DEPLOYMENT AUTOMATIONS.
57. Kanth, T. C. (2024). OPTIMIZING DATA SCIENCE WORKFLOWS IN CLOUD COMPUTING.
58. Kanth, T. C. (2023). CONTEMPORARY DEVOPS STRATEGIES FOR AUGMENTING SCALABLE AND RESILIENT APPLICATION DEPLOYMENT ACROSS MULTI-CLOUD ENVIRONMENTS.
59. Kanth, T. C. (2023). EXPLORING SERVER-LESS COMPUTING FOR EFFICIENT RESOURCE MANAGEMENT IN CLOUD ARCHITECTURES.
60. Nagarani, N., et al. “Self-attention based progressive generative adversarial network optimized with momentum search optimization algorithm for classification of brain tumor on MRI image.” Biomedical Signal Processing and Control 88 (2024): 105597.
61. Reka, R., R. Karthick, R. Saravana Ram, and Gurkirpal Singh. “Multi head self-attention gated graph convolutional network based multi‑attack intrusion detection in MANET.” Computers & Security 136 (2024): 103526.
62. Meenalochini, P., R. Karthick, and E. Sakthivel. “An Efficient Control Strategy for an Extended Switched Coupled Inductor Quasi-Z-Source Inverter for 3 Φ Grid Connected System.” Journal of Circuits, Systems and Computers 32.11 (2023): 2450011
63. Karthick, R., et al. “An optimal partitioning and floor planning for VLSI circuit design based on a hybrid bio-inspired whale optimization and adaptive bird swarm optimization (WO-ABSO) algorithm.” Journal of Circuits, Systems and Computers 32.08 (2023): 2350273.
64. Jasper Gnana Chandran, J., et al. “Dual-channel capsule generative adversarial network optimized with golden eagle optimization for pediatric bone age assessment from hand X-ray image.” International Journal of Pattern Recognition and Artificial Intelligence 37.02 (2023): 2354001.
65. Rajagopal RK, Karthick R, Meenalochini P, Kalaichelvi T. Deep Convolutional Spiking Neural Network optimized with Arithmetic optimization algorithm for lung disease detection using chest X-ray images. Biomedical Signal Processing and Control. 2023 Jan 1;79:104197.
66. Karthick, R., and P. Meenalochini. “Implementation of data cache block (DCB) in shared processor using field-programmable gate array (FPGA).” Journal of the National Science Foundation of Sri Lanka 48.4 (2020).
67. Karthick, R., A. Senthilselvi, P. Meenalochini, and S. Senthil Pandi. “Design and analysis of linear phase finite impulse response filter using water strider optimization algorithm in FPGA.” Circuits, Systems, and Signal Processing 41, no. 9 (2022): 5254-5282.
68. Karthick, R., and M. Sundararajan. “SPIDER-based out-of-order execution scheme for HtMPSOC.” International Journal of Advanced Intelligence paradigms 19.1 (2021): 28-41.
69. Karthick, R., Dawood, M.S. & Meenalochini, P. Analysis of vital signs using remote photoplethysmography (RPPG). J Ambient Intell Human Comput 14, 16729–16736 (2023). https://doi.org/10.1007/s12652-023-04683-w
70. Selvan, M. A., & Amali, S. M. J. (2024). RAINFALL DETECTION USING DEEP LEARNING TECHNIQUE.
71. Alapati, N., Prasad, B. V. V. S., Sharma, A., Kumari, G. R. P., Veeneetha, S. V., Srivalli, N., … & Sahitya, D. (2022, November). Prediction of Flight-fare using machine learning. In 2022 International Conference on Fourth Industrial Revolution Based Technology and Practices (ICFIRTP) (pp. 134-138). IEEE.
72. Murugan, M., & Natarajan, P. M. (2022). Agile Leader’s Emotional Resilience and Their Digital Innovations and Business Transformations in a Workplace in Msme Sector (New Normal) to Mitigate COVID-19 & Its Successors. International Journal of Professional Business Review, 7(4), e0755-e0755.
73. Murugan, M., & Prabadevi, M. N. (2023). Impact of Industry 6.0 on MSME Entrepreneur’s Performance and Entrepreneur’s Emotional Intelligence in the Service Industry in India. Revista de Gestão Social e Ambiental, 17(4), e03340-e03340.
74. Murugan, M., & Prabadevi, M. N. (2023, May). A study on the plant design software on the digital transformation and MSME entrepreneurs emotions towards business sustainability and autonomy in the energy service industry. In International Conference on Emerging Trends in Business and Management (ICETBM 2023) (pp. 284-303). Atlantis Press.
75. Murugan, M., & Prabadevi, M. N. (2024). 4 Impact of Artificial Intelligence. Explainable AI (XAI) for Sustainable Development: Trends and Applications, 58.
76. Murugan, M., & Prabadevi, M. N. (2024). Operational excellence (OpEx) through entrepreneur’s strategic business decision making and emotional contagion in the service industry. Salud, Ciencia y Tecnología-Serie de Conferencias, 3, 902-902.
77. Murugan, M., & Prabadevi, M. N. (2024). Leader’s Emotional Agility And Educational Organization’s Performance Through The Six Sigma Ways In The Engineering Service Industry. Educational Administration: Theory and Practice, 30(4), 917-926.
78. Murugan, M., & Prabadevi, M. N. (2024). Metaverse Platforms and Entrepreneurs’ Emotional Intelligence and Co-Creation Towards Quality Delivery in the Service Industry: New Normal. In Creator’s Economy in Metaverse Platforms: Empowering Stakeholders Through Omnichannel Approach (pp. 172-201). IGI Global.
79. Murugan, M., & Prabadevi, M. N. (2023, December). The Influence of Digital Reality with Automated System in Business Transformation and Operational Excellence on Entrepreneur’s Performance in the Engineering Service Industry. In 2023 Intelligent Computing and Control for Engineering and Business Systems (ICCEBS) (pp. 1-7). IEEE.
80. Murugan, M., & Prabadevi, M. N. (2023). The Need for Digital Twin and Psychological Engagement Through Emotional Intelligence in Start-Ups for Sustainable Business Strategy. Journal for ReAttach Therapy and Developmental Diversities, 6(9s (2)), 291-298.
81. Prabadevi, M. N., & Murugan, M. (2021). A Study on Emotional Intelligence and its Impact on Performance of Entrepreneurs in MSME Sectors. Turkish Online Journal of Qualitative Inquiry, 12(7).
82. MURUGAN, M. CO-CREATION OF MICRO, SMALL AND MEDIUM ENTERPRISES (MSME) ENTREPRENEURS EMOTIONAL INTELLIGENCE TO MITIGATE ORGANIZATIONAL ISSUES (NEW NORMAL).
83. Praseeda, C., Subramanian, K. P., Prabadevi, M. N., & Kalaivani, M. (Eds.). International Conference on Reinventing Business Practices, Startups and Sustainability–Virtual Conference. Shanlax Publications.